Applications of nanotechnology have increased the importance
of
research and nanocarriers, which have revolutionized the method of
drug delivery to treat several diseases, including cancer, in the
past few years. Cancer, one of the world’s fatal diseases,
has drawn scientists’ attention for its multidrug resistance
to various chemotherapeutic drugs. To minimize the side effects of
chemotherapeutic agents on healthy cells and to develop technological
advancement in drug delivery systems, scientists have developed an
alternative approach to delivering chemotherapeutic drugs at the targeted
site by integrating it inside the nanocarriers like synthetic polymers,
nanotubes, micelles, dendrimers, magnetic nanoparticles, quantum dots
(QDs), lipid nanoparticles, nano-biopolymeric substances, etc., which
has shown promising results in both preclinical and clinical trials
of cancer management. Besides that, nanocarriers, especially biopolymeric
nanoparticles, have received much attention from researchers due to
their cost-effectiveness, biodegradability, treatment efficacy, and
ability to target drug delivery by crossing the blood–brain
barrier. This review emphasizes the fabrication processes, the therapeutic
and theragnostic applications, and the importance of different biopolymeric
nanocarriers in targeting cancer both in vitro and in vivo, which conclude with the challenges and opportunities
of future exploration using biopolymeric nanocarriers in onco-therapy
with improved availability and reduced toxicity.